Ouabain was recently isolated from human plasma, bovine hypothalamus and bo
vine adrenal in attempts to identify endogenous substances inhibiting the c
ell membrane sodium pump. A number of radioimmunoassays have been developed
in order to study the clinical significance of ouabain. The results have b
een controversial with regard to the presence and chemical nature of plasma
ouabainlike immunoreactivity. We have now measured ouabain in healthy and
pregnant individuals using solid-phase extraction of plasma samples followe
d by a new radioimmunoassay with the extraordinary sensitivity of at least
2 fmol/tube (5 pmol/l). Plasma extracts, a previously isolated human plasma
ouabain-like compound and bovine hypothalamic inhibitory factor displaced
the tracer in parallel and eluted identically with ouabain in high-performa
nce liquid chromatography. Plasma ouabain immunoreactivity was found to be
much lower than reported previously: 12.6 +/- 1.3 pmol/l in healthy men (me
an +/- S.E, n = 20) and 9.4 +/- 0.7 pmol/l in women (n = 14). In pregnant w
omen (n = 28) plasma ouabain concentration was 16.3 +/- 3.0 pmol/l during t
he first trimester, 18.8 +/- 4.3 pmol/l during the second trimester and 24.
3 +/- 4.0 pmol/l during the third trimester (all P < 0.01 compared with non
-pregnant women). Plasma ouabain 3-5 days after the delivery was 13.6 +/- 1
.1 pmol/l (n = 10, P < 0.05-0.01 compared with second and third trimesters)
. The pregnancy-related changes in the plasma concentrations of ouabain res
embled those of cortisol. Therefore cortisol was measured from the same pla
sma samples and a significant positive correlation was found (r = 0.512, P
= 0.006). The similar profiles of plasma ouabain and cortisol during pregna
ncy and their rapid decreases postpartum are consistent with the adrenal co
rtical origin of ouabain and also show that the secretions of these hormone
s are possibly under the control of same factors.